Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice

References

• Ahrén, B. (2007). DPP-4 inhibitors. Best Practice & Research Clinical Endocrinology & Metabolism, 21, 517–533.10.1016/j.beem.2007.07.005
   Google Scholar
• Bank, U., Heimburg, A., Helmuth, M., Stefin, S., Lendeckel, U., Reinhold, D., ... Ansorge, S. (2006). Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)—A novel approach for the treatment of inflammatory bowel disease. International Immunopharmacology, 6, 1925–1934.10.1016/j.intimp.2006.09.014
   Google Scholar
• Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., ... Schnurr, M. (2010). Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut, 59, 1192–1199.10.1136/gut.2009.197822
   Google Scholar
• Brubaker, P. L., Izzo, A., Hill, M., & Drucker, D. J. (1997). Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. American Journal of Physiology, 272, E1050–8.
   Google Scholar
• Cooper, H. S., Murthy, S. N., Shah, R. S., & Sedergran, D. J. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation, 69, 238–249.
   Google Scholar
• Dhanvantari, S., Seidah, N. G., & Brubaker, P. L. (1996). Role of prohormone convertases in the tissue-specific processing of proglucagon. Molecular Endocrinology, 10, 342–355.
   Google Scholar
• Drucker, D. J. (2007). Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action. Diabetes Care, 30, 1335–1343.10.2337/dc07-0228
   Google Scholar
• Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996). Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proceedings of the National Academy of Sciences, 93, 7911–7916.10.1073/pnas.93.15.7911
   Google Scholar
• Drucker, D. J., Yusta, B., Boushey, R. P., DeForest, L., & Brubaker, P. L. (1999). Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. American Journal of Physiology, 276, G79–91.
   Google Scholar
• Eissele, R., Goke, R., Weichardt, U., Fehmann, H. C., Arnold, R., & Goke, B. (1994). Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study. Cell & Tissue Research, 276, 571–580.10.1007/BF00343955
   Google Scholar
• Hartmann, B., Thulesen, J., Kissow, H., Thulesen, S., Orskov, C., Ropke, C., ... Holst, J. J. (2000). Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology, 141, 4013–4020.
   Google Scholar
• Hayashi, Y., Yamamoto, M., Mizoguchi, H., Watanabe, C., Ito, R., Yamamoto, S., ... Murata, Y. (2009). Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet α-cells but not of intestinal L-cells. Molecular Endocrinology, 23, 1990–1999.10.1210/me.2009-0296
   Google Scholar
• Kitchen, P. A., Fitzgerald, A. J., Goodlad, R. A., Barley, N. F., Ghatei, M. A., Legon, S., … Forbes, A. (2000). Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. American Journal of physiology. Gastrointestinal Liver Physiology, 278, G425–8.
   Google Scholar
• Lakticova, V., Hutton-Thomas, R., Meyer, M., Gurkan, E., & Rice, L. B. (2006). Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora. Antimicrobial Agents and Chemotherapy, 50, 3117–3123.10.1128/AAC.00125-06
   Google Scholar
• Mimura, S., Ando, T., Ishiguro, K., Maeda, O., Watanabe, O., Ujihara, M., ... Goto, H. (2013). Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis. Scandinavian Journal of Gastroenterology, 48, 1152–1159.10.3109/00365521.2013.832366
   Google Scholar
• Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986). Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry, 261, 11880–11889.
   Google Scholar
• Mojsov, S., Weir, G. C., & Habener, J. F. (1987). Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. Journal of Clinical Investigation, 79, 616–619.10.1172/JCI112855
   Google Scholar
• Sigalet, D. L., Wallace, L. E., Holst, J. J., Martin, G. R., Kaji, T., Tanaka, H., & Sharkey, K. A. (2007). Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. AJP: Gastrointestinal and Liver Physiology, 293, G211–G221.10.1152/ajpgi.00530.2006
   Google Scholar
• Tsai, C. H., Hill, M., Asa, S. L., Brubaker, P. L., & Drucker, D. J. (1997). Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. American Journal of Physiology, 273, E77–84.
   Google Scholar
• Watanabe, C., Seino, Y., Miyahira, H., Yamamoto, M., Fukami, A., Ozaki, N., ... Hayashi, Y. (2012). Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides. Diabetes, 61, 74–84.10.2337/db11-0739
   Google Scholar
• Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993). Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Digestive Diseases and Sciences, 38, 665–673.10.1007/BF01316798
   Google Scholar
• Xiao, Q., Boushey, R. P., Drucker, D. J., & Brubaker, P. L. (1999). Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology, 117, 99–105.10.1016/S0016-5085(99)70555-X
   Google Scholar
• Yazbeck, R., Howarth, G. S., Geier, M. S., Demuth, H. U., & Abbott, C. A. (2008). Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice. Frontiers in Bioscience, 13, 6850–6858.10.2741/3193
   Google Scholar
• Yazbeck, R., Howarth, G. S., & Abbott, C. A. (2009). Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends in Pharmacological Sciences, 30, 600–607.10.1016/j.tips.2009.08.003
   Google Scholar
• Yazbeck, R., Sulda, M. L., Howarth, G. S., Bleich, A., Raber, K., von Hörsten, S., ... Abbott, C. A. (2010). Dipeptidyl peptidase expression during experimental colitis in mice. Inflammatory Bowel Diseases, 16, 1340–1351.10.1002/ibd.21241
   Google Scholar
• Yusta, B., Holland, D., Waschek, J. A., & Drucker, D. J. (2012). Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice. Endocrinology, 153, 2623–2632.10.1210/en.2012-1069
   Google Scholar